We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$194M
AUM Growth
+$6.3M
Cap. Flow
+$740K
Cap. Flow %
0.38%
Top 10 Hldgs %
57.19%
Holding
81
New
6
Increased
31
Reduced
36
Closed
2
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REET icon
51
iShares Global REIT ETF
REET
$5.05B
$338K 0.17%
14,744
+2,313
+19% +$54.6K
DBC icon
52
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$317K 0.16%
13,343
EEM icon
53
iShares MSCI Emerging Markets ETF
EEM
$28B
$306K 0.16%
7,748
ABT icon
54
Abbott
ABT
$175B
$305K 0.16%
3,009
+383
+15% +$40.4K
REGN icon
55
Regeneron Pharmaceuticals
REGN
$70.9B
$293K 0.15%
357
+50
+16% +$37.7K
TMO icon
56
Thermo Fisher Scientific
TMO
$198B
$274K 0.14%
+475
New +$268K
MDT icon
57
Medtronic
MDT
$106B
$265K 0.14%
3,284
-305
-8% -$24.9K
ESGE icon
58
iShares ESG Aware MSCI EM ETF
ESGE
$6.47B
$261K 0.13%
8,294
+35
+0.4% +$1.11K
INCY icon
59
Incyte
INCY
$23.4B
$255K 0.13%
3,525
+214
+6% +$16.7K
UNH icon
60
UnitedHealth
UNH
$387B
$254K 0.13%
536
+12
+2% +$5.79K
PFE icon
61
Pfizer
PFE
$143B
$248K 0.13%
6,074
-313
-5% -$13.5K
HYG icon
62
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$223K 0.11%
2,948
-631
-18% -$47.3K
PHG icon
63
Philips
PHG
$26.2B
$184K 0.09%
+11,679
New +$168K
ORTX
64
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$78.7K 0.04%
14,654
-1,835
-11% -$9.98K
ACHL
65
DELISTED
Achilles Therapeutics
ACHL
$72.4K 0.04%
75,625
+45,100
+148% +$48.9K
GERN icon
66
Geron
GERN
$924M
$59.9K 0.03%
27,582
+685
+3% +$1.95K
MREO
67
Mereo BioPharma
MREO
$49.5M
$59.2K 0.03%
83,700
+10,200
+14% +$9.18K
ALXO icon
68
ALX Oncology
ALXO
$283M
$58.9K 0.03%
+13,037
New +$98.8K
ANNX icon
69
Annexon
ANNX
$950M
$58.7K 0.03%
15,251
-205
-1% -$1.13K
KRON
70
DELISTED
Kronos Bio
KRON
$57.4K 0.03%
+39,295
New +$75.3K
JSPR icon
71
Jasper Therapeutics
JSPR
$24.8M
$54.8K 0.03%
3,029
-8,371
-73% -$155K
LONA
72
LeonaBio Inc
LONA
$67.8M
$54.1K 0.03%
2,163
-72
-3% -$2.32K
DM
73
DELISTED
Desktop Metal, Inc.
DM
$49K 0.03%
2,131
EIGR
74
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$46.3K 0.02%
1,723
+1,310
+317% +$60.9K
PSTX
75
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$46.3K 0.02%
15,040
-230
-2% -$1.38K

Similar funds

Forefront Analytics's Q1 2023 Portfolio in Review

As of Q1 2023, Forefront Analytics held 81 positions worth $194M, up 3.4% from $188M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Forefront Analytics's Q1 2023 filing shows 6 new, 31 increased, 36 reduced and 2 closed positions. Its largest new stake was iShares ESG Aware MSCI EAFE ETF: 273,342 shares worth $19.6M. The largest sale was Nuveen ESG Large-Cap Value ETF, an estimated $16M.

By sector, the portfolio is most concentrated in Healthcare at 1.5% of assets, up from 1.3% a quarter earlier, followed by Technology and Industrials.

  • Forefront Analytics's largest Q1 2023 buy was iShares ESG Aware MSCI EAFE ETF: 273,342 shares worth $19.6M.
  • Forefront Analytics added most to State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q1 2023, an estimated $674K increase.
  • Forefront Analytics's biggest Q1 2023 reduction was Nuveen ESG Large-Cap Value ETF, cutting an estimated $16M.
  • Forefront Analytics fully exited Dyadic International in Q1 2023, selling an estimated $70.2K.
  • Forefront Analytics's ten largest holdings make up 57% of its $194M portfolio in Q1 2023.
  • Forefront Analytics opened 6 new positions and closed 2 in Q1 2023.
  • Forefront Analytics's portfolio value rose 3.4% quarter-over-quarter to $194M.

Based on Forefront Analytics's 13F filing for Q1 2023, filed 12 May 2023.